Seasoned Financial Leader with 30 Years of Experience Brought on to Help Drive Strategic Growth and Innovation
PALM BEACH GARDENS, Fla., June 3, 2024 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the appointment of Greg Tibbitts as the company’s Interim Chief Financial Officer. In his new role, Tibbitts will leverage his extensive financial expertise and leadership experience to guide Accelus through its next phase of growth and innovation in the minimally invasive spine surgery market.
“Greg brings over 30 years of financial leadership and a proven track record of success,” said Kevin McGann, President and Chief Executive Officer of Accelus. “His deep expertise in managing companies of varying sizes, overseeing complex mergers, and driving significant revenue growth is invaluable. Greg’s leadership will be instrumental in driving our financial strategy and supporting our continued innovation in spinal implant technologies.”
Tibbitts’ impressive career includes serving as the Chief Financial Officer for multiple public and private companies, including Accriva Diagnostics, Accumetrics Inc., CryoCor Inc., and Elitra Pharmaceuticals. In addition to his CFO roles, Tibbitts has extensive experience in auditing and financial management. He previously served as a Senior Auditor and Senior Audit Manager for Ernst & Young and as a Division Controller for ITT Financial. He currently serves as a board member for Mainz Biomed, a diagnostics company, and previously held board positions with CoImmune and IDMI Pharma, Inc., both biotechnologies companies. Tibbitts holds a B.B.A. from the University of San Diego and an M.B.A. from San Diego State University.
“I am excited to join Accelus as Interim CFO and contribute to its mission of delivering unparalleled service to customers as a nimble and responsive provider of minimally invasive spine solutions,” Tibbitts said. “I look forward to working with the team to build on the company’s strong financial foundation and support its vision of enhancing surgical efficacy through innovations in lumbar spine procedures.”
About Accelus
Accelus, a worldwide leader in expandable spinal implant technology, is dedicated to enhancing surgical procedures and patient outcomes through innovative spinal solutions. The company’s commitment to excellence is evident in its advanced Adaptive Geometry™ technologies specifically designed for transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), endoscopic-assisted, percutaneous and lateral spine surgeries. For more information on Accelus and its innovative product portfolio, please visit www.accelusinc.com.
# # #
